XML 48 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense

Total stock-based compensation expense recorded related to awards granted to employees and non-employees was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Research and development

 

$

21,115

 

 

$

10,826

 

 

$

6,050

 

General and administrative

 

 

13,631

 

 

 

7,663

 

 

 

5,579

 

Total stock-based compensation expense

 

$

34,746

 

 

$

18,489

 

 

$

11,629

 

Summary of Activity under Plans

Activity under the Company’s 2015 and 2019 Plans and 2023 Inducement Plan is set forth below:

 

 

 

Outstanding Options

 

 

 

 

 

 

 

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Balance, January 1, 2024

 

 

6,269,975

 

 

$

15.53

 

 

 

7.82

 

 

$

128.49

 

Options granted

 

 

3,247,538

 

 

$

41.88

 

 

 

 

 

 

 

Options exercised

 

 

(1,118,695

)

 

$

11.16

 

 

 

 

 

 

 

Options canceled

 

 

(661,223

)

 

$

29.57

 

 

 

 

 

 

 

Balance, December 31, 2024

 

 

7,737,595

 

 

$

26.06

 

 

 

7.89

 

 

 

43.01

 

Exercisable as of December 31, 2024

 

 

3,185,690

 

 

$

15.63

 

 

 

6.62

 

 

$

31.04

 

Vested and expected to vest as of
   December 31, 2024

 

 

7,737,595

 

 

$

26.06

 

 

 

7.89

 

 

$

43.01

 

 

Assumptions Used to Calculate Fair Values of Options

The fair values of options were calculated using the assumptions set forth below:

 

 

 

Year Ended December 31,

 

 

2024

 

2023

 

2022

Expected term

 

5.5 - 6.1 years

 

6.1 years

 

6.1 years

Expected volatility

 

76.8% - 81.3%

 

81.8% - 86.9%

 

86.8% - 89.9%

Risk-free interest rate

 

3.6% - 4.7%

 

3.6% - 4.8%

 

1.6% - 4.1%

Dividend yield

 

0%

 

0%

 

0%